4//SEC Filing
Herberts Curt A. III 4
Accession 0001209191-18-023597
CIK 0001001233other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:09 PM ET
Size
14.3 KB
Accession
0001209191-18-023597
Insider Transaction Report
Form 4
Herberts Curt A. III
Senior VP & CBO
Transactions
- Exercise/Conversion
Common Stock
2018-04-02$9.41/sh+715$6,728→ 15,340 total - Sale
Common Stock
2018-04-02$18.30/sh−2,278$41,684→ 14,625 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-04-02−715→ 16,605 totalExercise: $9.41Exp: 2025-12-07→ Common Stock (715 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2018-04-02−1,563→ 53,125 totalExercise: $3.50Exp: 2027-01-25→ Common Stock (1,563 underlying) - Exercise/Conversion
Common Stock
2018-04-02$3.50/sh+1,563$5,471→ 16,903 total
Footnotes (5)
- [F1]All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
- [F2]The price reported is a weighted average price. The shares were sold at prices ranging from $18.069 to $18.80 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes (a) 8,375 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date; and (b) 6,250 shares subject to restricted stock units granted on December 8, 2015 that will vest on December 8, 2018, subject to the Reporting Person's continued service with the Issuer through such date.
- [F4]One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
- [F5]One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the January 26, 2017 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001691262
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:09 PM ET
- Size
- 14.3 KB